ClinVar Miner

Submissions for variant NM_001023570.4(IQCB1):c.424_425del (p.Phe142fs)

dbSNP: rs750962965
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 13
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Illumina Laboratory Services, Illumina RCV000001905 SCV000915984 pathogenic Senior-Loken syndrome 5 2017-04-28 criteria provided, single submitter clinical testing The IQCB1 c.424_425delTT (p.Phe142ProfsTer5) variant is a frameshift variant that is predicted to result in premature termination of the protein. The p.Phe142ProfsTer5 variant has been reported in three studies in which it is found in a total of nine individuals with Senior Loken syndrome, including in seven patients in a homozygous state and in two patients in a compound heterozygous state who both carried a null variant on the second allele (Otto et al. 2005; Estrada-Cuzcano et al. 2011; Halbritter et al. 2013). The p.Phe142ProfsTer5 variant was absent from 347 control subjects but is reported at a frequency of 0.00023 in the European (non-Finnish) population of the Exome Aggregation Consortium. Based on the evidence, the p.Phe142ProfsTer5 variant is classified as pathogenic for Senior Loken syndrome. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.
Labcorp Genetics (formerly Invitae), Labcorp RCV000822567 SCV000963376 pathogenic Nephronophthisis 2025-01-13 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Phe142Profs*5) in the IQCB1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in IQCB1 are known to be pathogenic (PMID: 15723066, 21901789, 23559409, 28041643). This variant is present in population databases (rs750962965, gnomAD 0.02%). This premature translational stop signal has been observed in individual(s) with Leber congenital amaurosis and Senior-L√∏ken syndrome (PMID: 15723066, 20881296, 21866095, 23188109, 24625443, 28041643, 28832562). This variant is also known as c.224_225delTT, p.F142fsX146. ClinVar contains an entry for this variant (Variation ID: 1831). For these reasons, this variant has been classified as Pathogenic.
Blueprint Genetics RCV001073766 SCV001239326 pathogenic Retinal dystrophy 2017-12-06 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV001093170 SCV001250020 pathogenic not provided 2018-05-01 criteria provided, single submitter clinical testing
Ocular Genomics Institute, Massachusetts Eye and Ear RCV000001905 SCV001573560 pathogenic Senior-Loken syndrome 5 2021-04-08 criteria provided, single submitter research The IQCB1 c.424_425del variant was identified in an individual with retinitis pigmentosa with a presumed recessive inheritance pattern. Through a review of available evidence we were able to apply the following criteria: PVS1, PM2, PM3. Based on this evidence we have classified this variant as Pathogenic.
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen RCV001093170 SCV001762005 pathogenic not provided 2021-06-17 criteria provided, single submitter clinical testing
GeneDx RCV001093170 SCV001824779 pathogenic not provided 2021-11-23 criteria provided, single submitter clinical testing Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 23446637, 21866095, 15723066, 28832562, 20881296, 29453417, 31980526, 32581362)
Fulgent Genetics, Fulgent Genetics RCV000001905 SCV002813901 pathogenic Senior-Loken syndrome 5 2024-05-08 criteria provided, single submitter clinical testing
Baylor Genetics RCV000001905 SCV004192436 pathogenic Senior-Loken syndrome 5 2024-03-25 criteria provided, single submitter clinical testing
Institute of Human Genetics, Univ. Regensburg, Univ. Regensburg RCV001073766 SCV005068612 pathogenic Retinal dystrophy 2021-01-01 criteria provided, single submitter clinical testing
OMIM RCV000001905 SCV000022063 pathogenic Senior-Loken syndrome 5 2011-02-11 no assertion criteria provided literature only
NIHR Bioresource Rare Diseases, University of Cambridge RCV000505085 SCV000598854 pathogenic Leber congenital amaurosis 2015-01-01 no assertion criteria provided research
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ RCV000001905 SCV000804661 pathogenic Senior-Loken syndrome 5 2016-09-01 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.